arthritis-research.com/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Arthritis Research & Therapy
official impact factor 4.45
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Arthritis Research & Therapy
  • Subscriptions

Submit a manuscript Register Sign up for article alerts Contact us Follow us on Twitter

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most viewed RSS
      • Last 30 days
      • Last year
      • All time
  • Issues
  • Supplements
  • Article collections

Page 2 of 2

 Previous 1 2

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

51.

15769
Accesses

Review   Free Highly Accessed

Interleukin-6: discovery of a pleiotropic cytokine

Tadamitsu Kishimoto Arthritis Research & Therapy 2006, 8(Suppl 2):S2 (28 July 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

52.

15766
Accesses

Research article   Open Access Highly Accessed

Relationship between physical activity and stiff or painful joints in mid-aged women and older women: a 3-year prospective study

Kristiann C Heesch, Yvette D Miller, Wendy J Brown Arthritis Research & Therapy 2007, 9:R34 (29 March 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | 1 comment

53.

15497
Accesses

Review   Free Highly Accessed

Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics

Robert Terkeltaub, David A Bushinsky, Michael A Becker Arthritis Research & Therapy 2006, 8(Suppl 1):S4 (12 April 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

54.

15464
Accesses

Research article   Open Access Highly Accessed

Anti-TNF-α antibody allows healing of joint damage in polyarthritic transgenic mice

David J Shealy, Paul H Wooley, Eva Emmell, Amy Volk, Amy Rosenberg, George Treacy, Carrie L Wagner, Lois Mayton, Don E Griswold, Xiao-yu R Song Arthritis Res 2002, 4:R7 (28 June 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

55.

15422
Accesses

Research article   Open Access Highly Accessed

Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study

Steeve Tat, Jean-Pierre Pelletier, Josep Vergés, Daniel Lajeunesse, Eulàlia Montell, Hassan Fahmi, Martin Lavigne, Johanne Martel-Pelletier Arthritis Research & Therapy 2007, 9:R117 (9 November 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

A combination of glucosamine sulphate and chondroitin sulphate markedly reduces the resorptive activity of subchondral bone osteoblasts, suggesting a positive effect on early bone structural changes in osteoarthritis.

56.

15320
Accesses

Research article   Open Access Highly Accessed

A critical appraisal of guidelines for the management of knee osteoarthritis using Appraisal of Guidelines Research and Evaluation criteria

Stéphane Poitras, Jérôme Avouac, Michel Rossignol, Bernard Avouac, Christine Cedraschi, Margareta Nordin, Chantal Rousseaux, Sylvie Rozenberg, Bernard Savarieau, Philippe Thoumie, Jean-Pierre Valat, Éric Vignon, Pascal Hilliquin Arthritis Research & Therapy 2007, 9:R126 (6 December 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Guidelines for treating knee osteoarthritis were found to lack educational information and differ in treatments addressed when they were reviewed using the Appraisal of Guidelines Research and Evaluation (AGREE) criteria.

57.

15273
Accesses

Review   Free Highly Accessed

Arthritis and Pain. Neurogenic origin of joint pain

Jason J McDougall Arthritis Research & Therapy 2006, 8:220 (10 November 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

58.

15203
Accesses

Review   Free Highly Accessed

Negative regulation of cytokine signaling and immune responses by SOCS proteins

Akihiko Yoshimura, Hitomi Nishinakamura, Yumiko Matsumura, Toshikatsu Hanada Arthritis Research & Therapy 2005, 7:100-110 (30 March 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

59.

15071
Accesses

Review   Free

Macrophages in rheumatoid arthritis

Raimund W Kinne, Rolf Bräuer, Bruno Stuhlmüller, Ernesta Palombo-Kinne, Gerd-R Burmester Arthritis Res 2000, 2:189-202 (12 April 2000)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

60.

15065
Accesses

Review   Free Highly Accessed

Arthritis and pain. Psychosocial aspects in the management of arthritis pain

Catherine L Backman Arthritis Research & Therapy 2006, 8:221 (5 December 2006)

Abstract | Full text | PDF | PubMed | 1 comment

61.

15025
Accesses

Review   Free Highly Accessed

Magnetic resonance imaging in psoriatic arthritis: a review of the literature

Fiona McQueen, Marissa Lassere, Mikkel Østergaard Arthritis Research & Therapy 2006, 8:207 (23 March 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

62.

15022
Accesses

Review   Free

Signaling for survival and apoptosis in the immune system

Tak W Mak, Wen-Chen Yeh Arthritis Res 2002, 4(Suppl 3):S243-S252 (9 May 2002)

Abstract | Full text | PDF | PubMed

63.

14992
Accesses

Research article   Open Access Highly Accessed

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

R Andrew Moore, Sheena Derry, Geoffrey T Makinson, Henry J McQuay Arthritis Research & Therapy 2005, 7:R644-R665 (24 March 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

64.

14967
Accesses

Review   Free

Is juvenile rheumatoid arthritis/juvenile idiopathic arthritis different from rheumatoid arthritis?

Sampath Prahalad, David N Glass Arthritis Res 2002, 4(Suppl 3):303-310 (24 July 2002)

Abstract | Full text | PDF

65.

14861
Accesses

Research article   Open Access Highly Accessed

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis

Fiona E McCann, Andrew C Palfreeman, Melanie Andrews, Dany P Perocheau, Julia J Inglis, Peter Schafer, Marc Feldmann, Richard O Williams, Fionula M Brennan Arthritis Research & Therapy 2010, 12:R107 (2 June 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

66.

14734
Accesses

Review   Free

The clinical relevance of autoantibodies in scleroderma

Khanh T Ho, John D Reveille Arthritis Res Ther 2003, 5:80-93 (12 February 2003)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

67.

14666
Accesses

Research article   Open Access Highly Accessed

Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study

Tuulikki Sokka, Sergio Toloza, Maurizio Cutolo, Hannu Kautiainen, Heidi Makinen, Feride Gogus, Vlado Skakic, Humeira Badsha, Tõnu Peets, Asta Baranauskaite, Pál Géher, Ilona Újfalussy, Fotini N Skopouli, Maria Mavrommati, Rieke Alten, Christof Pohl, Jean Sibilia, Andrea Stancati, Fausto Salaffi, Wojciech Romanowski, Danuta Zarowny-Wierzbinska, Dan Henrohn, Barry Bresnihan, Patricia Minnock, Lene Knudsen, Johannes WG Jacobs, Jaime Calvo-Alen, Juris Lazovskis, Geraldo Pinheiro, Dmitry Karateev, Daina Andersone, Sylejman Rexhepi, Yusuf Yazici, Theodore Pincus, the QUEST-RA Group et al. Arthritis Research & Therapy 2009, 11:R7 (14 January 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Rheumatoid arthritis was more severe in women in an analysis of more than 6,000 patients, although the effects of gender on standard disease activity measures may explain the difference.

68.

14665
Accesses

Research article   Open Access Highly Accessed

The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties

Robert M Bennett, Ronald Friend, Kim D Jones, Rachel Ward, Bobby K Han, Rebecca L Ross Arthritis Research & Therapy 2009, 11:R120 (10 August 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

69.

14605
Accesses

Research article   Open Access Highly Accessed

Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols

Eleni Douni, Petros P Sfikakis, Sylva Haralambous, Peter Fernandes, George Kollias Arthritis Res Ther 2004, 6:R65-R72 (7 November 2003)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

70.

14579
Accesses

Research article   Open Access

Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture — primary culture cells markedly differ from fourth-passage cells

Thomas Zimmermann, Elke Kunisch, Robert Pfeiffer, Astrid Hirth, Hans-Detlev Stahl, Ulrich Sack, Anke Laube, Eckehard Liesaus, Andreas Roth, Ernesta Palombo-Kinne, Frank Emmrich, Raimund W Kinne Arthritis Res 2001, 3:72-76 (21 November 2000)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

71.

14571
Accesses

Review   Free

Matrix metalloproteinases in arthritic disease

Gillian Murphy, Vera Knäuper, Susan Atkinson, George Butler, William English, Mike Hutton, Jan Stracke, Ian Clark Arthritis Res 2002, 4(Suppl 3):S39-S49 (9 May 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

72.

14554
Accesses

Review   Free Highly Accessed

A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritis

James N Pencharz, Elizabeth Grigoriadis, Gwenderlyn F Jansz, Claire Bombardier Arthritis Res 2002, 4:36-44 (16 October 2001)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

73.

14358
Accesses

Research article   Open Access Highly Accessed

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment

Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, Rene Westhovens, Patrick Durez, Filip Van den Bosch, Eric M Veys, Herman Mielants, Luc De Clerck, Anne Peretz, Michel Malaise, Leon Verbruggen, Nathan Vastesaeger, Anja Geldhof, Luc Boullart, Filip De Keyser Arthritis Research & Therapy 2005, 7:R1063-R1071 (8 July 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

74.

14329
Accesses

Review   Free Highly Accessed

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

Martinus AM van Boekel, Erik R Vossenaar, Frank HJ van den Hoogen, Walther J van Venrooij Arthritis Res 2002, 4:87-93 (6 November 2001)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

75.

14281
Accesses

Review   Free

The paradigm of IL-6: from basic science to medicine

Tetsuji Naka, Norihiro Nishimoto, Tadamitsu Kishimoto Arthritis Res 2002, 4(Suppl 3):S233-S242 (9 May 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

76.

14280
Accesses

Review   Free Highly Accessed

Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases

Nathan J Zvaifler Arthritis Research & Therapy 2006, 8:210 (9 May 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

77.

14235
Accesses

Review   Free Highly Accessed

Biology of RANK, RANKL, and osteoprotegerin

Brendan F Boyce, Lianping Xing Arthritis Research & Therapy 2007, 9(Suppl 1):S1 (29 June 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

78.

14208
Accesses

Research article   Open Access

Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1

Helena d'Elia, Lars-Åke Mattsson, Claes Ohlsson, Elisabeth Nordborg, Hans Carlsten Arthritis Res Ther 2003, 5:R202-R209 (1 May 2003)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

79.

14074
Accesses

Research article   Open Access Highly Accessed

A pilot study of IL-1 inhibition by anakinra in acute gout

Alexander So, Thibaut De Smedt, Sylvie Revaz, Jürg Tschopp Arthritis Research & Therapy 2007, 9:R28 (12 March 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

In a pilot study on 10 patients with gouty arthritis, IL-1 blockade with anakinra gave rapid relief of inflammatory symptoms where standard treatments had failed or were not tolerated.

80.

14050
Accesses

Review   Free Highly Accessed

Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia

Manuel Martinez-Lavin Arthritis Research & Therapy 2007, 9:216 (6 July 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

81.

14032
Accesses

Review   Free Highly Accessed

Gout. Novel therapies for treatment of gout and hyperuricemia

Robert Terkeltaub Arthritis Research & Therapy 2009, 11:236 (23 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

82.

14000
Accesses

Research article   Open Access

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

Raphaela Goldbach-Mansky, Jennifer Lee, Angela McCoy, Joseph Hoxworth, Cheryl Yarboro, Josef S Smolen, Günter Steiner, Antony Rosen, Cindy Zhang, Henri A Ménard, Zhi Jie Zhou, Timo Palosuo, Walther J Van Venrooij, Ronald L Wilder, John H Klippel, H Ralph Schumacher, Hani S El-Gabalawy Arthritis Res 2000, 2:236-243 (31 March 2000)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

83.

13981
Accesses

Review   Free Highly Accessed

Oxidation in rheumatoid arthritis

Carol A Hitchon, Hani S El-Gabalawy Arthritis Res Ther 2004, 6:265-278 (13 October 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

84.

13974
Accesses

Commentary   Free Highly Accessed

Does a positive anti-CCP test identify a distinct arthritis entity?

Thomas Skogh Arthritis Research & Therapy 2005, 7:230-232 (16 September 2005)

Abstract | Full text | PDF | PubMed

85.

13954
Accesses

Review   Free Highly Accessed

Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management

Flavia V Castelino, John Varga Arthritis Research & Therapy 2010, 12:213 (23 August 2010)

Abstract | Full text | PDF | PubMed

86.

13705
Accesses

Research article   Open Access Highly Accessed

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Michael A Becker, H Ralph Schumacher, Luis R Espinoza, Alvin F Wells, Patricia MacDonald, Eric Lloyd, Christopher Lademacher Arthritis Research & Therapy 2010, 12:R63 (6 April 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

87.

13651
Accesses

Research article   Open Access Highly Accessed

Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model

Jianyong Shou, Christopher M Bull, Li Li, Hui-Rong Qian, Tao Wei, Shuang Luo, Douglas Perkins, Patricia J Solenberg, Seng-Lai Tan, Xin-Yi Chen, Neal W Roehm, Jeffrey A Wolos, Jude E Onyia Arthritis Research & Therapy 2006, 8:R28 (10 January 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

88.

13627
Accesses

Research article   Open Access Highly Accessed

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

Juan J Gomez-Reino, Loreto Carmona, the BIOBADASER Group Arthritis Research & Therapy 2006, 8:R29 (6 January 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

89.

13610
Accesses

Review   Free

Perspectives for TNF-α-targeting therapies

Hanns-Martin Lorenz, Joachim R Kalden Arthritis Res 2002, 4(Suppl 3):S17-S24 (9 May 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

90.

13371
Accesses

Review   Free

Angiogenesis in rheumatoid arthritis

Ewa M Paleolog Arthritis Res 2002, 4(Suppl 3):S81-S90 (9 May 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

91.

13357
Accesses

Review   Free Highly Accessed

The life cycle of chondrocytes in the developing skeleton

Lillian Shum, Glen Nuckolls Arthritis Res 2002, 4:94-106 (8 November 2001)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

92.

13244
Accesses

Review   Free Highly Accessed

The evolving clinical profile of abatacept (CTLA4–Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis

Eric M Ruderman, Richard M Pope Arthritis Research & Therapy 2005, 7(Suppl 2):S21-S25 (16 March 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

93.

13166
Accesses

Research article   Open Access Highly Accessed

Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen

Julia J Inglis, Gabriel Criado, Mino Medghalchi, Melanie Andrews, Ann Sandison, Marc Feldmann, Richard O Williams Arthritis Research & Therapy 2007, 9:R113 (29 October 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

C57BL/6 mice may be useful for testing new therapeutics, particularly those directed against T cells, and investigating the action of current therapies in rheumatoid arthritis.

94.

13067
Accesses

Research article   Open Access Highly Accessed

Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells

Kutty Nandakumar, Johan Bäcklund, Mikael Vestberg, Rikard Holmdahl Arthritis Res Ther 2004, 6:R544-R550 (23 September 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

95.

13011
Accesses

Research article   Open Access Highly Accessed

Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis

C Thomas G Appleton, David D McErlain, Vasek Pitelka, Neil Schwartz, Suzanne M Bernier, James L Henry, David W Holdsworth, Frank Beier Arthritis Research & Therapy 2007, 9:R13 (6 February 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

96.

13010
Accesses

Research article   Open Access Highly Accessed

Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides

Merete Pedersen, Søren Jacobsen, Mette Klarlund, Bo V Pedersen, Allan Wiik, Jan Wohlfahrt, Morten Frisch Arthritis Research & Therapy 2006, 8:R133 (27 July 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

97.

13001
Accesses

Research article   Open Access Highly Accessed

Rheumatic Diseases in China

Qing Zeng, Ren Chen, John Darmawan, Zheng Xiao, Su Chen, Richard Wigley, Shun Le Chen, Nai Zhang Arthritis Research & Therapy 2008, 10:R17 (31 January 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

A large population study found that the incidence of certain rheumatic diseases in China is becoming more like that of Western countries, but different joints are affected compared to Caucasian populations.

98.

12992
Accesses

Review   Free Highly Accessed

Epstein–Barr virus and rheumatoid arthritis: is there a link?

Karen H Costenbader, Elizabeth W Karlson Arthritis Research & Therapy 2006, 8:204 (16 January 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

99.

12949
Accesses

Supplement   Free

Autoantibodies in rheumatoid arthritis and their clinical significance

Günter Steiner, Josef Smolen Arthritis Res 2002, 4(Suppl 2):S1-S5 (26 April 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

100.

12925
Accesses

Research article   Open Access Highly Accessed

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

Jacques Tebib, Xavier Mariette, Pierre Bourgeois, René-Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine, Jean Sibilia Arthritis Research & Therapy 2009, 11:R95 (23 June 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

A small clinical trial has shown masitinib to be generally well tolerated and effective in the treatment of rheumatoid arthritis, indicating the need for further placebo-controlled studies.

Page 2 of 2

 Previous 1 2


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.